Genexine ranked among the top searched stocks on 2 days in the past month.


As of 10:31 AM on the 19th, Genexine is trading at 101,200 KRW, down 5.68% from the previous day. This is an 8.7% increase compared to February 10. Genexine is known as a company specializing in the development of biopharmaceuticals.

Today, foreigners are tentatively recorded as net sellers of 4,626 shares. Over the past 5 days, individual investors have net bought 290,610 shares, while foreigners and institutions have net sold 289,283 shares and 7,937 shares, respectively.


On February 18, Genexine was a market issue with the news of "immune-oncology drug technology export causing a surge."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing